Turcot’s syndrome confirmed by molecular biological tests - 06/05/08
Turcot’s syndrome (Turcot et al. 1959) is clinically characterized by the co-existence of a primary brain tumour with familial adenomatous polyposis or hereditary non-polypotic colorectal carcinoma.
This paper reports a 45 year-old woman who presented in 1995 with an anaplastic astrocytoma (grade III, WHO classification). Treatment included surgery, radiotherapy, first and second line chemotherapy (nitrosourea followed by a platinum salt). It was then recognized that the patient’s brother had colorectal cancer. A genetic study detected a germ-line mutation on the hMSH2 gene, specific for HNPCC (human non-polypotic colorectal cancer). Colonoscopy was normal. Eight years after diagnosis the patient developed a cerebral glioma.
An indicative personal or familial history may provide clues to the diagnosis of Turcot’s syndrome. Molecular diagnosis may contribute to the choice of appropriate treatment.
30 references.
Esquema
© 2006 Elsevier Masson SAS. Tous droits réservés.
Vol 162 - N° 6-7
P. 741-746 - juin 2006 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.